Health CanadaType II
APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that...
Published: February 16, 2026Recall ID: 81606Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
APO-CANDESARTAN
Additional Source Details
| Field | Value |
|---|---|
| N I D | 81606 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/apo-candesartan-affected-lots-were-manufactured-using-active-ingredient-was-out |
| Issue | Product quality |
| Title | APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolution |
| Product | APO-CANDESARTAN |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2026-02-16 |
| Organization | Drugs and health products |
| Recall class | Type II |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |